GH vs. EXAS
Compare and contrast key facts about Guardant Health, Inc. (GH) and Exact Sciences Corporation (EXAS).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: GH or EXAS.
Correlation
The correlation between GH and EXAS is 0.47, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
Performance
GH vs. EXAS - Performance Comparison
Key characteristics
GH:
1.79
EXAS:
-0.18
GH:
2.59
EXAS:
-0.00
GH:
1.29
EXAS:
1.00
GH:
1.32
EXAS:
-0.22
GH:
6.04
EXAS:
-0.68
GH:
19.57%
EXAS:
24.05%
GH:
69.66%
EXAS:
59.73%
GH:
-91.03%
EXAS:
-98.01%
GH:
-76.73%
EXAS:
-65.77%
Fundamentals
GH:
$5.46B
EXAS:
$10.06B
GH:
-$3.39
EXAS:
-$5.53
GH:
7.50
EXAS:
3.07
GH:
55.67
EXAS:
3.46
GH:
$774.00M
EXAS:
$2.83B
GH:
$474.77M
EXAS:
$1.93B
GH:
-$397.86M
EXAS:
-$848.74M
Returns By Period
In the year-to-date period, GH achieves a 36.43% return, which is significantly higher than EXAS's -5.57% return.
GH
36.43%
4.70%
45.79%
123.61%
-13.95%
N/A
EXAS
-5.57%
31.63%
-0.32%
-10.79%
-8.37%
8.80%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
GH vs. EXAS — Risk-Adjusted Performance Rank
GH
EXAS
GH vs. EXAS - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Guardant Health, Inc. (GH) and Exact Sciences Corporation (EXAS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
GH vs. EXAS - Dividend Comparison
Neither GH nor EXAS has paid dividends to shareholders.
Drawdowns
GH vs. EXAS - Drawdown Comparison
The maximum GH drawdown since its inception was -91.03%, smaller than the maximum EXAS drawdown of -98.01%. Use the drawdown chart below to compare losses from any high point for GH and EXAS. For additional features, visit the drawdowns tool.
Volatility
GH vs. EXAS - Volatility Comparison
Guardant Health, Inc. (GH) has a higher volatility of 21.27% compared to Exact Sciences Corporation (EXAS) at 17.33%. This indicates that GH's price experiences larger fluctuations and is considered to be riskier than EXAS based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
GH vs. EXAS - Financials Comparison
This section allows you to compare key financial metrics between Guardant Health, Inc. and Exact Sciences Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
GH vs. EXAS - Profitability Comparison
GH - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Guardant Health, Inc. reported a gross profit of 128.75M and revenue of 203.47M. Therefore, the gross margin over that period was 63.3%.
EXAS - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Exact Sciences Corporation reported a gross profit of 500.55M and revenue of 706.79M. Therefore, the gross margin over that period was 70.8%.
GH - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Guardant Health, Inc. reported an operating income of -111.04M and revenue of 203.47M, resulting in an operating margin of -54.6%.
EXAS - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Exact Sciences Corporation reported an operating income of -96.01M and revenue of 706.79M, resulting in an operating margin of -13.6%.
GH - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Guardant Health, Inc. reported a net income of -95.16M and revenue of 203.47M, resulting in a net margin of -46.8%.
EXAS - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Exact Sciences Corporation reported a net income of -101.22M and revenue of 706.79M, resulting in a net margin of -14.3%.